NCT05110339View on ClinicalTrials.gov

Efficacy of Dexmedetomidine on Postoperative Analgesia

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Postoperative Pain
Interventions
DRUG

Ropivacaine plus dexmedetomidine

Erector spinae block with ropivacaine at a dose of 0.5% plus dexmedetomidine at 0.3 mcg / kg.

DRUG

Ropivacaine

Erector spinae block with ropivacaine at a dose of 0.5%.

Trial Locations (1)

87000

Jose Camilo Muñoz Chaves, Matamoros

All Listed Sponsors
collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Universidad Autónoma de Tamaulipas

OTHER

NCT05110339 - Efficacy of Dexmedetomidine on Postoperative Analgesia | Biotech Hunter | Biotech Hunter